Interferon therapy for chronic hepatitis C

Alter, 1995, Epidemiology of hepatitis C in the West, 15, 5 Alter, 1989, Hepatitis C and miles to go before we sleep, New England Journal of Medicine, 321, 1538, 10.1056/NEJM198911303212208 Andreone, 1994, Indomethacin enhances serum 2′5′-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis, Journal of Hepatology, 21, 984, 10.1016/S0168-8278(05)80606-3 Angelico, 1995, Recombinant interferon alpha and ursodeoxycholic acid versus interferon alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up, American Journal of Gastroenterology, 90, 263 Bacon, 1995, Lymphoblastoid interferon improves long-term response to a six month course of treatment when compared with recombinant interferon alfa 2b: results of an international trial (abstract), Hepatology, 22, 152A, 10.1016/0270-9139(95)94331-5 Benhamou, 1995, Long-term lymphoblastoid interferon enhances sustained responses and improves histological activity up to 12 months post-treatment (abstract), Hepatology, 22, 151 A Bennett, 1995, Justification of a single 6-month course of interferon for histologically mild chronic hepatitis C (abstract), Hepatology, 22, 290A Bodenheimer, 1990, Histological and clinical correlation in chronic hepatitis C (abstract), Hepatology, 12, 844 Bodenheimer, 1994, Tolerance and safety of oral ribavirin treatment of chronic hepatitis C: a multicenter trial, Hepatology, 20, 207A Boucher, 1995, Interferon and ursodeoxycholic acid combined therapy in the treatment of chronic viral C hepatitis: results from a controlled randomized trial of 80 patients, Hepatology, 21, 322 Bresters, 1992, Disappearance of hepatitis C virus RNA in plasma during interferon alpha-2b treatment in hemophilia patients, Scandinavian Journal of Gastroenterology, 27, 166, 10.3109/00365529208999943 Brillanti, 1991, Effect of alpha-interferon therapy on hepatitis C viremia in community-acquired chronic non-A, non-B hepatitis: a quantitative polymerase chain reaction study, Journal of Medical Virology, 34, 136, 10.1002/jmv.1890340213 Brillanti, 1994, A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C, Gastroenterology, 107, 812, 10.1016/0016-5085(94)90131-7 Castilla, 1991, Transforming growth factor beta I and alpha in chronic liver disease, 324, 933 Causse, 1991, Comparison of I or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A non-B hepatitis, Gastroenterology, 101, 497, 10.1016/0016-5085(91)90030-O Chayama, 1991, Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C, Hepatology, 13, 1040, 10.1002/hep.1840130606 Chemello, 1995, Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon alfa, Journal of Viral Hepatitis, 2, 91, 10.1111/j.1365-2893.1995.tb00012.x Cimino, 1991, Treatment of chronic hepatitis C with recombinant interferon alfa, Italian Journal of Gastroenterology, 23, 399 Davis, 1990, Recombinant alpha interferon treatment of non-A, non-B (type C) hepatitis: review of studies and recommendations, Journal of Hepatology, 11, 72, 10.1016/0168-8278(90)90168-Q Davis, 1994, Interferon treatment of cirrhotic patients with chronic hepatitis C: a logical intervention, American Journal of Gastroenterology, 89, 658 Davis, 1986, Interferon in viral hepatitis: role in pathogenesis and treatment, Hepatology, 6, 1038, 10.1002/hep.1840060537 Davis, 1989, Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized, controlled trial, New England Journal of Medicine, 321, 1501, 10.1056/NEJM198911303212203 Davis, 1990, Predictors of response to recombinant alpha interferon treatment in patients with chronic hepatitis C, Hepatology, 12, 905 Davis, 1994, Therapy for chronic hepatitis C, Gastroenterology Clinics of North America, 23, 603, 10.1016/S0889-8553(21)00156-4 Davis, 1994, Clinical predictors of response to recombinant alpha interferon treatment in patients with chronic non-A, non-B hepatitis (hepatitis C), Journal of Viral Hepatitis, 1, 55, 10.1111/j.1365-2893.1994.tb00062.x Di Bisceglie, 1989, Recombinant interferon alfa therapy for chronic hepatitis C, 321, 1506 Di Bisceglie, 1992, A pilot study of ribavirin therapy for chronic hepatitis C, Hepatology, 16, 649, 10.1002/hep.1840160307 Dienstag, 1983, Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features, Gastroenterology, 85, 439, 10.1016/0016-5085(83)90336-0 Enomoto, 1994, Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformational poly-morphism analysis, Journal of General Virology, 75, 1361, 10.1099/0022-1317-75-6-1361 Farrell, 1991, Prediction of response to interferon in patients with chronic active hepatitis C and evidence that this improves hepatic metabolic function, Gastroenterologia Japonica, 26, 243, 10.1007/BF02779310 Feinman, 1991, Treatment of chronic non-A, non-B hepatitis blood related and sporadic with recombinant interferon A (abstract), Hepatology, 14, 71 A Giudici-Cipriani, 1991, Therapy of cheonic non-A, non-B hepatitis with interferon alfa-2b, 37, 85 Gomez-Rubio, 1990, Prolonged treatment (18 months) of chronic hepatitis C with recombinant alpha-interferon in comparison with a control group, Journal of Hepatology, 11, S63, 10.1016/0168-8278(90)90166-O Gonzalez-Peralta, 1994, Pathogenetic mechanisms on hepatocellular damage in chronic hepatitis C virus infection, Journal of Hepatology, 21, 255, 10.1016/S0168-8278(05)80405-2 Hagiwara, 1992, Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alpa, Hepatology, 15, 37, 10.1002/hep.1840150108 Hoofnagle, 1986, Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon: a preliminary report, New England and Journal of Medicine, 315, 1575, 10.1056/NEJM198612183152503 Iwarson, 1979, Progression of hepatitis non-A, non-B to chronic active hepatitis: a histologic follow-up of two cases, Journal of Clinical Pathology, 32, 351, 10.1136/jcp.32.4.351 Jacyna, 1989, Randomized controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis, British Medical Journal, 298, 80, 10.1136/bmj.298.6666.80 Jeffers, 1991, Minimizing sampling error with laparoscopic guided liver biopsy of right and left lobes (abstract), Gastrointestinal Endoscopy, 37, 266 Jouet, 1994, Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B C hepatitis, Gastroenterology, 106, 686, 10.1016/0016-5085(94)90703-X Kakumu, 1993, A pilot study of ribavirin and interferon beta for the treatment for chronic hepatitis C, Gastroenterology, 105, 507, 10.1016/0016-5085(93)90727-T Kasahara, 1995, Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial, Hepatology, 21, 291, 10.1002/hep.1840210205 Kato, 1992, Interferon-inducible gene expression in chimpanzee liver infected with hepatitis C, Virology, 190, 856, 10.1016/0042-6822(92)90925-F Kiyosawa, 1982, Significance of blood transfusion in non-A, non-B chronic liver disease in Japan, Vox Sanguis, 43, 45, 10.1111/j.1423-0410.1982.tb01116.x Kuo, 1989, An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis, Science, 244, 362, 10.1126/science.2496467 Lau, 1993, Significance of serum hepatitis C virus RNA levels in chronic hepatitis, Lancet, 341, 1501, 10.1016/0140-6736(93)90635-T Lim, 1994, Progressive cholestatic hepatitis leading to sub-fuminant hepatic failure in an immunosuppressed patient with organ transmitted hepatitis C virus infection, Gastroenterology, 106, 248, 10.1016/S0016-5085(94)95829-7 Makris, 1991, A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs, Blood, 78, 1672, 10.1182/blood.V78.7.1672.1672 Marcellin, 1991, Recombinant human alpha-interferon in patients with chronic non-A non-B hepatitis: a multicenter randomized controlled trial from France, Hepatology, 13, 393, 10.1002/hep.1840130302 Marcellin, 1995, Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C, Gastroenterology, 109, 156, 10.1016/0016-5085(95)90281-3 Martinot-Peignoux, 1995, Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C, Hepatology, 22, 1050, 10.1002/hep.1840220406 Métreau, 1991, Twelve-month treatment compared to 6-month treatment does not improve the efficacy of alpha-interferon in NANB chronic active hepatitis (abstract), Hepatology, 14, 72A Nelson, 1995, Defining the role of intrahepatic HCV-specific cytotoxic T-lymphocytes in chronic hepatitis C (abstract), Hepatology, 22, 287A, 10.1016/0270-9139(95)94872-4 Nousbaum, 1995, Hepatitis C virus 1b (II) infection I France and Italy, Annals of Internal Medicine, 122, 161, 10.7326/0003-4819-122-3-199502010-00001 Okada, 1992, The degree of variability in the amino terminal region of the E2/NS I protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients, Hepatology, 16, 619, 10.1002/hep.1840160302 Olynyk, 1995, Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C, Gastroenterology, 108, 1104, 10.1016/0016-5085(95)90209-0 Omata, 1991, Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant alpha-interferon for chronic non-A, non-B hepatitis, Digestive Diseases and Sciences, 36, 1217, 10.1007/BF01307512 Orito, 1995, Loss of serum HCV RNA at week 4 of interferon alpha therapy is associated with more favorable long-term response in patients with chronic hepatitis C, Journal of Medical Virology, 46, 109, 10.1002/jmv.1890460205 Peters, 1986, The interferon system in acute and chronic viral hepatitis, vol 8, 453 Poynard, 1995, A comparison of three interferon alfa-2b regimens for the long term treatment of chronic non-A, non-B hepatitis, New England Journal of Medicine, 332, 1457, 10.1056/NEJM199506013322201 Rakela, 1993, An open-label, randomized parallel evaluation of one, three and six million units of interferon alfa-2a in the sixth-month treatment of patients with chronic non-A, non-B hepatitis (abstract), Gastroenterology, 104, A976 Realdi, 1990, Recombinant human interferon alfa-2a in community-acquired non-A, non-B chronic active hepatitis, 11, S68 Reichard, 1991, Ribavirin treatment for chronic hepatitis C, Lancet, 337, 1058, 10.1016/0140-6736(91)91707-2 Roddenberry, 1991, Detection of hepatitis C viral RNA in liver tissue of chronic hepatitis C patients before and after treatment with interferon α-2b (abstract), Hepatology, 14, 75A Sàez-Royuela, 1991, High doses of recombinant alpha-interferon or gamma interferon for chronic hepatitis C: a randomized controlled trial, Hepatology, 13, 327, 10.1002/hep.1840130220 Saracco, 1990, A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitis, Journal of Hepatology, 11, 43, 10.1016/0168-8278(90)90162-K Schoeman, 1990, Chronic non-A, non-B hepatitis: lack of correlation between biochemical and morphological activity, and effects of immunosuppressive therapy on disease progression, Australian and New Zealand Journal of Medicine, 20, 56, 10.1111/j.1445-5994.1990.tb00372.x Schvarcz, 1991, Scandinavian Journal of Infectious Diseases, 23, 413, 10.3109/00365549109075088 Schvarcz, 1991, Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A, non-B hepatitis, Liver, 11, 30, 10.1111/j.1600-0676.1991.tb00487.x Schvarcz, 1995, Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone, Journal of Medical Virology, 46, 43, 10.1002/jmv.1890460110 Seeff, 1992, Longterm mortality after transfusion-associated non-A, non-B hepatitis, New England Journal of Medicine, 327, 1906, 10.1056/NEJM199212313272703 Shindo, 1991, Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C, Annals of Internal Medicine, 115, 700, 10.7326/0003-4819-115-9-700 Simon, 1995, Natural alfa interferon (Alferon) treatment of chronic hepatitis C in previously untreated patients (abstract), Hepatology, 22, 151A, 10.1016/0270-9139(95)94330-7 Takahashi, 1993, Natural history of chronic hepatitis C, American Journal of Gastroenterology, 88, 240 Tiné, 1991, Interferon for non-A, non-B chronic hepatitis: a meta-analysis of randomised clinical trials, Journal of Hepatology, 13, 192, 10.1016/0168-8278(91)90814-R Tong, 1993, Treatment of patients with chronic HCV infection with a novel type-a interferon, concensus interferon (abstract), Hepatology, 18, 150A, 10.1016/0270-9139(93)92130-R Tong, 1995, Clinical outcomes after transfusion-associated hepatitis C, New England Journal of Medicine, 332, 1463, 10.1056/NEJM199506013322202 Weiland, 1990, Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experience, Journal of Hepatology, 11, 57, 10.1016/0168-8278(90)90165-N